急性胰腺炎诊断预测模型的前瞻性验证
这项前瞻性诊断研究纳入2020年1月1日至2021年3月9日美国东北部2个大型学术医学中心急诊科连续就诊、血清脂肪酶至少3倍正常上限的成人患者,排除外院转入、恶性肿瘤伴腹腔转移、急性创伤或意识改变者,最终349例完成评分。预测模型纳入初始血清脂肪酶水平、既往急性胰腺炎发作次数、既往胆石症、2个月内腹部手术、上腹痛、疼痛加重、疼痛至就诊时间及急诊就诊时疼痛程度。评分曲线下面积0.91,≥6分准确度最高(F评分82.0),诊断急性胰腺炎敏感度81.5%、特异度85.9%、阳性预测值82.6%、阴性预测值85.1%;预测阳性者更常接受早期CT或MRI(74.8% vs 57.2%,P < .001)。作者认为该模型应用可能避免不必要的确认性影像检查。
要点
- 对急诊科血清脂肪酶≥3倍正常上限的成人,预测模型评分≥6分诊断急性胰腺炎的敏感度81.5%、特异度85.9%、阳性预测值82.6%、阴性预测值85.1%。
- 模型在349例前瞻性队列中曲线下面积0.91,评分≥6分F评分最高(82.0)。
- 预测为急性胰腺炎者更常接受早期CT或MRI:评分≥6分者116/155(74.8%)vs 评分<6分者111/194(57.2%),P < .001。
- 早期影像发现替代诊断的比例随评分升高而降低:≥6分者8/116(6.9%),≥7分者1/93(1.1%),≥8分者1/73(1.4%)。
- 作者认为该预测模型的应用可能用于避免不必要的确认性影像检查。
适用人群与场景
- 2020年1月1日至2021年3月9日在美国东北部2个大型学术医学中心急诊科连续就诊、血清脂肪酶至少3倍正常上限的成人患者。
- 排除外院转入、恶性肿瘤伴明确腹腔转移、急性创伤或意识改变的患者。
诊断标准与关键阈值
- 预测模型评分项目包括初始血清脂肪酶水平、既往急性胰腺炎发作次数、既往胆石症、2个月内腹部手术、上腹痛、疼痛加重、疼痛至就诊时间及急诊就诊时疼痛程度。
- 评分≥6分对应诊断急性胰腺炎的敏感度81.5%、特异度85.9%、阳性预测值82.6%、阴性预测值85.1%,F评分82.0为最高准确度。
研究设计与关键结果
- 研究类型为前瞻性诊断研究,纳入2个大型学术医学中心急诊科连续成人患者349例,平均(SD)年龄53.0(18.8)岁,女性184例(52.7%),黑人66例(18.9%),白人199例(57.0%)。
- 预测模型评分诊断急性胰腺炎的曲线下面积为0.91。
- 评分≥6分诊断急性胰腺炎的敏感度81.5%、特异度85.9%、阳性预测值82.6%、阴性预测值85.1%,F评分82.0为最高准确度。
- 预测为急性胰腺炎者更常接受早期CT或MRI:评分≥6分者116/155(74.8%)vs 评分<6分者111/194(57.2%),P < .001。
- 早期影像发现替代诊断:评分≥6分者8/116(6.9%),评分≥7分者1/93(1.1%),评分≥8分者1/73(1.4%)。
证据类型、等级与局限
- 证据类型:前瞻性诊断研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急诊科血清脂肪酶至少3倍正常上限的成人,该预测模型评分≥6分诊断急性胰腺炎敏感度81.5%、特异度85.9%,作者认为其应用可能用于避免不必要的确认性影像检查。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: While most patients with acute pancreatitis (AP) fulfill diagnostic criteria with characteristic abdominal pain and serum lipase levels of at least 3 times the upper limit of normal (reference range) at presentation, early imaging is often used for confirmation. A prior prediction model and corresponding point-based score were developed using nonimaging parameters to diagnose AP in patients presenting to the emergency department (ED).
OBJECTIVE: To evaluate the performance of the prediction model to diagnose AP in a prospective patient cohort.
DESIGN, SETTING, AND PARTICIPANTS: This prospective diagnostic study included consecutive adult patients presenting to the ED between January 1, 2020, and March 9, 2021, at 2 large academic medical centers in the northeastern US with serum lipase levels at least 3 times the upper limit of normal. Patients transferred from outside institutions or with malignant disease and established intra-abdominal metastases, acute trauma, or altered mentation were excluded. Data were analyzed from October 15 to October 23, 2023.
EXPOSURES: Participants were assigned scores for initial serum lipase level, number of prior AP episodes, prior cholelithiasis, abdominal surgery within 2 months, presence of epigastric pain, pain of worsening severity, duration from pain onset to presentation, and pain level at ED presentation.
MAIN OUTCOME AND MEASURES: A final diagnosis of AP, established by expert review of hospitalization records.
RESULTS: Prospective scores in 349 participants (mean [SD] age, 53.0 [18.8] years; 184 women [52.7%]; 66 Black [18.9%]; 199 White [57.0%]) demonstrated an area under the receiver operating characteristics curve of 0.91. A score of at least 6 points achieved highest accuracy (F score, 82.0), corresponding to a sensitivity of 81.5%, specificity of 85.9%, positive predictive value of 82.6%, and negative predictive value of 85.1% for AP diagnosis. Early computed tomography or magnetic resonance imaging was performed more often in participants predicted to have AP (116 of 155 [74.8%] with a score ≥6 vs 111 of 194 [57.2%] with a score <6; P < .001). Early imaging revealed an alternative diagnosis in 8 of 116 participants (6.9%) with scores of at least 6 points, 1 of 93 (1.1%) with scores of at least 7 points, and 1 of 73 (1.4%) with scores of at least 8 points.
CONCLUSIONS AND RELEVANCE: In this multicenter diagnostic study, the prediction model demonstrated excellent AP diagnostic accuracy. Its application may be used to avoid unnecessary confirmatory imaging.
参考来源
- Jin DX, Lacson R, Eskian M, et al. Prospective Validation of a Prediction Model for the Diagnosis of Acute Pancreatitis. JAMA Netw Open. 2024. PMID: 38941094. doi:10.1001/jamanetworkopen.2024.19014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。